Cite
The Mitochondrial-Derived Peptide MOTS-c May Refine Mortality and Cardiovascular Risk Prediction in Chronic Hemodialysis Patients: A Multicenter Cohort Study.
MLA
Bolignano, Davide, et al. “The Mitochondrial-Derived Peptide MOTS-c May Refine Mortality and Cardiovascular Risk Prediction in Chronic Hemodialysis Patients: A Multicenter Cohort Study.” Blood Purification, vol. 53, no. 10, Oct. 2024, pp. 824–37. EBSCOhost, https://doi.org/10.1159/000540303.
APA
Bolignano, D., Greco, M., Presta, P., Duni, A., Zicarelli, M., Mercuri, S., Pappas, E., Lakkas, L., Musolino, M., Naka, K. K., Misiti, R., Foti, D. P., Andreucci, M., Coppolino, G., & Dounousi, E. (2024). The Mitochondrial-Derived Peptide MOTS-c May Refine Mortality and Cardiovascular Risk Prediction in Chronic Hemodialysis Patients: A Multicenter Cohort Study. Blood Purification, 53(10), 824–837. https://doi.org/10.1159/000540303
Chicago
Bolignano, Davide, Marta Greco, Pierangela Presta, Anila Duni, Mariateresa Zicarelli, Simone Mercuri, Efthymios Pappas, et al. 2024. “The Mitochondrial-Derived Peptide MOTS-c May Refine Mortality and Cardiovascular Risk Prediction in Chronic Hemodialysis Patients: A Multicenter Cohort Study.” Blood Purification 53 (10): 824–37. doi:10.1159/000540303.